A novel approach to formulation factor of aceclofenac eye drops efficiency evaluation based on physicochemical characteristics of in vitro and in vivo permeation

Saudi Pharmaceutical Journal

Volumn 22, Issue 3, 2014, Pages 240-245

  Dave, Vivek ^a   Paliwal, Sarvesh ^a  

^a BANASTHALI UNIVERSITY   (India)

Author keywords

Aceclofenac; Cornea; Permeation; Transcorneal

Indexed keywords

ACECLOFENAC; DICLOFENAC; DRUG PRESERVATIVE; METHYL PARABEN; PROPYL PARABEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORNEA INJURY; DRUG EFFECT; DRUG FORMULATION; DRUG PENETRATION; DRUG POTENCY; DRUG SCREENING; DRUG SOLUTION; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; LIPOPHILICITY; NONHUMAN; OCULAR SURFACE DISEASE; PARTITION COEFFICIENT; PH; PHYSICAL CHEMISTRY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFLAMMATION; POSTOPERATIVE PAIN; SURFACE TENSION;

EID: 84904067960     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2013.03.001     Document Type: Article

References (15)

1. Deepika A., Dhananjay P., Ashim K.M., Indu P.K. Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation by microdialysis sampling of aqueous humour. Int. J. Pharm. 2007, 338:21-26.
2. Faruk O., Emin K., Umit U.I., Selim K., Süleyman S.I., Nursabah E.B., Atila B. Penetration of topical and oral ofloxacin into the aqueous and vitreous humor of inflamed rabbit eyes. Int. J. Pharm. 2000, 204:91-95.
3. Ghate D., Edelhauser H.F. Ocular drug delivery. Exp. Opin. Drug Deliv. 2006, 3:275-287.
4. Ghosh A., Nayak U.K., Roy P. Development, evaluation and method selection for the Preparation of lamivudine microspheres. Int. J. Pharm. 2007, 9:67-71.
5. Grass G.M., Cooper E.R., Robinson J.R. Mechanisms of corneal drug penetration III: modeling of molecular transport. J. Pharm. Sci. 2006, 77:124-126.
6. Grass G.M., Robinson J.R. Mechanism of corneal drug penetration I: in vivo and in vitro kinetics. J. Pharm. Sci. 1988, 77:3-14.
7. Malhotra M., Majumdar D.K. In vitro transcorneal permeation of ketorolac tromethamine from buffered and unbuffered aqueous ocular drops. Ind. J. Exp. Biol. 1997, 35:941-947.
8. Martin M., Awn R., Assumpta M., Mary M., Michael H.M. Pharmacokinetics of amikacin and chloramphenicol in the aqueous humor of rabbits. Antimicrob. Agents Chemother. 1991, 22:1791-1798.
9. Mitra A.K. Ophthalmic Drug Delivery Systems 2003, Marcel Dekker Inc., New York. 2nd ed.
10. Munish Ahuja, Dhake Avinash S., Sharma Surendra K., Majumdar Dipak K. Ocular delivery of NSAIDs. AAPS J. 2008, 10(2).
11. Prausnitz M.R., Noonan J.S. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J. Pharm. Sci. 1998, 87:1479-1488.
12. Quintana-Hau J.D., Cruz-Olmos E., Lopez-Sanchez M.I., Sanchez-Castellanos V., Baiza-Duran L., Gonzalez J.R., Tornero-Montano, Mondragon-Flores R., Hernandez-Santoyo A. Characterization of the novel ophthalmic drug carrier Sophisen in two of its derivatives: 3A Ofteno and Modusik-A Ofteno. Drug Dev. Ind. Pharm. 2005, 31:263-269.
13. Rojanasakul Y., Robinson J.R. Transport mechanisms of the cornea: characterization of barrier permselectivity. Int. J. Pharmacol. 1989, 55:237-246.
14. Sasaki H., Tei C., Yamamura K., Nishida K., Namamura J. J. Pharm. Pharmacol. 1994, 46:871-875.
15. Singla Shivali, Majumdar D.K., Goyal Sachin, Khilnani Gurudas Evidence of carrier mediated transport of ascorbic acid through mammalian cornea. Saudi Pharmaceut. J. 2011, 19:165-170.